Literature DB >> 30678606

The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.

Tufan Çınar1, Yavuz Karabağ2, Veysel Ozan Tanık3, Metin Çağdaş2, İbrahim Rencüzoğulları2, Ahmet Öz1.   

Abstract

Objective: Contrast-induced acute kidney injury (CI-AKI) is a well-known and life-threating complication in patients with ST-elevation myocardial infraction (STEMI) after primary percutaneous coronary intervention (PCI). Several studies demonstrated that the Thrombolysis in Myocardial Infarction (TIMI) Risk Index (TRI) is a useful risk model in predicting early mortality in patients with acute coronary syndrome. The objective of the present study is to evaluate the predictive value of admission TRI for the occurrence of CI-AKI in patients with STEMI treated with primary PCI.
Methods: This retrospective study was consisted of a total of 660 consecutive STEMI patients who had undergone primary PCI from December 2015 to March 2017.The primary end-point was CI-AKI incidence after primary PCI during the in-hospital course.
Results: The TRI of CI-AKI group was higher than the non-CI-AKI group (24.2 (19.3-32.2) vs. 17.5 (12.9-24.3), p < .001, respectively). In multivariable logistic regression analysis, TRI was found to be an independent predictors of CI-AKI (OR: 1.055, 95% CI: 1.027-1.083, p < .001). The discriminative power of TRI with regards to occurrence of CI-AKI was superior compared to its components.
Conclusion: This study is the first to demonstrate that TRI can be used to predict the development of CI-AKI in patients with STEMI who undergo primary PCI. Health professionals might be able to use the TRI risk score to predict CI-AKI due to the simplicity and accessibility of this risk index.

Entities:  

Keywords:  ST-elevation myocardial infraction; TIMI risk index; contrast-induced acute kidney injury; primary percutaneous coronary intervention

Year:  2019        PMID: 30678606     DOI: 10.1080/00015385.2018.1551263

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  4 in total

1.  Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Qi Yu; Jia-Jia Zhu; Wen-Xian Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-04-21       Impact factor: 2.298

2.  Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country.

Authors:  Ashraf O Oweis; Sameeha A Alshelleh; Nesreen Saadeh; Mohamad I Jarrah; Rasheed Ibdah; Karem H Alzoubi
Journal:  Int J Vasc Med       Date:  2020-12-21

3.  Comparative analysis of four established risk scores for predicting contrast induced acute kidney injury after primary percutaneous coronary interventions.

Authors:  Rajesh Kumar; Kamran Ahmed Khan; Lajpat Rai; Bashir Ahmed Solangi; Ali Ammar; Muhammad Nauman Khan; Ifikhar Ahmed; Bilal Ahmed; Tahir Saghir; Jawaid Akbar Sial; Musa Karim
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-29

4.  Predictive value of creatine kinase MB for contrast-induced acute kidney injury among myocardial infarction patients.

Authors:  Wen Wei; Lingyu Zhang; Yunhan Zhang; Ronghui Tang; Miao Zhao; Zhidong Huang; Jin Liu; Danyuan Xu; Yibo He; Bo Wang; Haozhang Huang; Qiang Li; Mengfei Lin; Yong Liu; Kaihong Chen; Shiqun Chen
Journal:  BMC Cardiovasc Disord       Date:  2021-07-13       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.